David Stollman
About David Stollman
David Stollman serves as the Global Compliance Director at Adaptimmune, where he has worked since 2020. He has extensive experience in compliance and regulatory roles across various pharmaceutical companies, including Incyte, AstraZeneca, and Shire Pharmaceuticals.
Work at Adaptimmune
David Stollman has served as the Global Compliance Director at Adaptimmune since 2020. In this role, he is responsible for overseeing compliance with laws, regulations, and internal policies. He provides clear interpretations of key operational principles to stakeholders and develops effective communication channels for employees to report concerns regarding compliance violations. His position is based in Philadelphia, Pennsylvania.
Previous Experience in Compliance
Before joining Adaptimmune, David Stollman held several significant positions in compliance. He was the Chief Compliance Officer at Incyte from 2012 to 2014. He also worked at Ferring Pharmaceuticals as the Director of Commercial Healthcare Compliance from 2017 to 2020. His experience includes roles at AstraZeneca, where he served as Regulatory Project Manager, Associate Director of Compliance Policy & Investigations, and Brand Compliance & Ethics Leader.
Education and Expertise
David Stollman earned his Juris Doctor degree from Widener University School of Law, specializing in Health Law, from 2000 to 2004. He also holds a Bachelor of Science degree in Chemistry from Bucknell University, which he completed from 1993 to 1997. His expertise includes implementing compliance and ethics programs in accordance with Sarbanes-Oxley and the Federal Sentencing Guidelines.
Background in Regulatory Compliance
David Stollman's career in regulatory compliance spans multiple organizations and roles. He worked at Navigant Consulting Limited as Associate Director, focusing on Healthcare Life Sciences, Disputes, Investigations, Compliance, and Regulatory from 2015 to 2020. He has also held compliance positions at GlaxoSmithKline and Shire Pharmaceuticals, contributing to his extensive knowledge in the field.
Risk Management and Internal Investigations
In his roles, David Stollman has developed risk management and improvement plans to address identified risks within organizations. He oversees and coordinates internal investigations to ensure compliance with applicable laws and regulations. His work emphasizes the importance of maintaining ethical standards and compliance within the pharmaceutical industry.